Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs NVT✓SelectedUSD · NVTMRNA vs NVT performance historyLatest closeAs of-2.17%11/20
Stock and ETF performance explorer

MRNA vs NVT

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+147.0%
NVT return
+98.3%
Excess return
+48.7%
Maximum drawdown
-86.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioNVTExcessAlpha
1D-2.2%-5.8%+3.6%-1.2%
7D-12.7%-11.2%-1.5%-11.0%
30D-20.7%-30.2%+9.5%-16.4%
3M+46.3%-33.9%+80.2%+54.4%
6M+305.2%-36.9%+342.1%+321.1%
YTD+561.2%+0.5%+560.7%+476.8%
1Y+772.1%+1.0%+771.1%+657.6%
3Y+147.0%+95.5%+51.5%+43.7%
All+147.0%+98.3%+48.7%+43.7%

Cumulative growth

Daily Returns

Daily percentage return beside NVT.

Daily Out/Under-Performance

Portfolio return minus NVT return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × NVT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded NVT wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling